ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.40
+0.15 (1.82%)
At close: Aug 27, 2026, 4:00 PM EDT
8.41
+0.01 (0.12%)
After-hours: Aug 27, 2026, 7:59 PM EDT
ImmunityBio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -992.36 | -351.4 | -413.56 | -583.2 | -416.57 | -346.79 |
Depreciation & Amortization | 16.5 | 15.43 | 17.55 | 18.51 | 18.26 | 14.24 |
Other Amortization | 0.1 | 0.1 | 22.59 | 42.4 | 16.28 | 0.06 |
Asset Writedown & Restructuring Costs | 14.02 | 14.02 | - | 0.89 | 2.01 | - |
Loss (Gain) From Sale of Investments | -6.48 | -2.75 | -0.86 | 1.45 | 5.51 | 5.02 |
Stock-Based Compensation | 34.31 | 36.81 | 34.43 | 49.16 | 40.18 | 57.18 |
Other Operating Activities | 680.42 | 37.18 | -31.97 | 100.2 | 4.82 | 14.98 |
Change in Accounts Receivable | -31.35 | -40.21 | -2.36 | - | - | - |
Change in Inventory | -11.93 | -6.33 | -8.27 | - | - | - |
Change in Accounts Payable | 3.24 | -0.19 | -3.17 | -6.48 | 8 | -3.72 |
Change in Other Net Operating Assets | 12.38 | -7.6 | -5.62 | 10.3 | -16 | -15.4 |
Operating Cash Flow | -281.14 | -304.94 | -391.24 | -366.76 | -337.51 | -274.42 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -6.94 | -3.85 | -6.89 | -30.58 | -78.16 | -33.56 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 20.5 |
Sale (Purchase) of Intangibles | -0.44 | -0.41 | - | - | -21.23 | - |
Investment in Securities | -269.53 | -145.55 | -5.36 | 0.11 | 126.69 | -71.82 |
Investing Cash Flow | -276.91 | -149.8 | -12.25 | -30.47 | 27.3 | -84.89 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 2.88 | - | - | - | - |
Long-Term Debt Issued | - | - | 96.96 | 451.46 | 174.13 | 338.5 |
Total Debt Issued | 77.89 | 2.88 | 96.96 | 451.46 | 174.13 | 338.5 |
Long-Term Debt Repaid | - | -1.16 | -0.06 | -0.08 | -0.06 | - |
Net Debt Issued (Repaid) | 74.96 | 1.72 | 96.89 | 451.39 | 174.07 | 338.5 |
Issuance of Common Stock | 429.88 | 400.78 | 190.2 | 100.86 | 60.5 | 169.99 |
Repurchase of Common Stock | -8.05 | -2.27 | -5.47 | -3.44 | -0.62 | -4.06 |
Other Financing Activities | - | - | - | 9.54 | -0.34 | 1.02 |
Financing Cash Flow | 496.78 | 400.24 | 281.63 | 558.34 | 233.61 | 505.44 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.07 | 0.02 | -0.02 | -0.29 | 0.28 | 0.05 |
Net Cash Flow | -61.2 | -54.48 | -121.88 | 160.82 | -76.32 | 146.19 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -288.07 | -308.78 | -398.12 | -397.34 | -415.67 | -307.98 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -173.76% | -272.56% | -2700.06% | -63881.19% | -173196.25% | -32974.52% |
Free Cash Flow Per Share | -0.29 | -0.34 | -0.57 | -0.78 | -1.04 | -0.79 |
Levered Free Cash Flow | -186.56 | -213.36 | -256.31 | -234.66 | -299.03 | -170.3 |
Unlevered Free Cash Flow | -115.01 | -143.03 | -182.44 | -196.31 | -275.62 | -161.08 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 76.94 | 71.32 | 92.32 | 77.19 | 35.44 | 2.11 |
Cash Income Tax Paid | 0.01 | - | 0.02 | 0.01 | 0 | 0.01 |
Change in Working Capital | -27.65 | -54.33 | -19.42 | 3.83 | -8 | -19.11 |